Nasdaq
LKFT
Lakefront Biotherapeutics
- Health Care
- Belgium
- Listed 2015
- 1 day
- +0.2%
- 1 month
- −14.6%
- 1 year
- −20.3%
$26.13 · Mkt cap $1.72B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Lakefront Biotherapeutics
$26.13 · Mkt cap $1.72B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Lakefront Biotherapeutics trades under the ticker LKFT on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2015. Its market capitalisation is $1.72B. The last closing price was $26.13, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −20.3%, and −14.6% over the past month. Returns are price returns and exclude dividends.
This page exists because LKFT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.